At the completion of this activity, participants will be able to:
1. Explain the significance and prevalence of C. diff infections
2. Review treatment guideline updates for management of C. diff infections
3. Describe the evidence for fidaxomicin and vancomycin use for treatment of C. diff infections
4. Discuss the application of C. diff treatment guidelines to practice
Session date:
10/18/2021 - 12:00pm to 1:00pm EDT
Location:
FH Learning Center #1 & Zoom
https://highmarkhealth.zoom.us/j/95789466145
Meeting ID: 957 8946 6145
Passcode: 782710
United States
See map: Google Maps
Add to calendar:
- 1.00 ACPE Pharmacy
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance